Green PolkaDot Box Granted License for Exclusive U.S. Virtual Club Market Rights to Greenleaf Medical's New Ingredient, Appethyl(R)

Online Membership Club for Purchasing Organic and Non-GMO Natural Foods at Wholesale Prices Online Secures U.S. Virtual Club Market Rights to Nutracon 2013's Best New Ingredient, Appethyl(R) for Acute and Long-Term Appetite Suppression

        Print
| Source: Green PolkaDot Box Incorporated

MOUNT PLEASANT, Utah, June 24, 2014 (GLOBE NEWSWIRE) -- Green PolkaDot Box Incorporated (OTC:GPDB) "GPDB" announced today that it has entered into an agreement with Greenleaf Medical for an exclusive license to use the intellectual property pertaining to and the ingredient known as Appethyl® in the U.S. virtual club market for humans and in the ecommerce channel on a non-exclusive basis.

"We are thrilled to be selected by Greenleaf Medical as one of its few partners in the U.S. for distribution of a breakthrough product that we estimate will have broad appeal to potentially millions of consumers seeking the benefits of acute and long-term appetite suppression," says GPDB CEO Rod Smith. "We anticipate that Appethyl® will become a major revenue generator, a 'gateway' product, a potential flagship product, that can attract consumers who are seeking a healthier dietary lifestyle to Green PolkaDot Box."

Appethyl® is a unique formula that is based on an extract from spinach components—thylakoids—with scientifically identified mechanisms for suppressing hunger signals and promoting reward in the brain. The patented spinach extract, used for acute appetite suppression, is designed to reduce hunger while also reducing blood glucose levels.

Awarded "Best New Ingredient" at the 2013 Nutracon conference, Appethyl® was recognized for scientific merit, efficacy, market potential, safety, innovation and the ability to increase market credibility.

"We are confident that the Green PolkaDot customer profile is an ideal fit for Appethyl® since it is a natural product with positive hunger control benefits. Greenleaf Medical is very proud to bring the best clinical research from Sweden to the U.S. through this virtual club market and related e-commerce channels," said Anders Struksnes, Chief Executive Officer for Greenleaf Medical.

The beneficial health effects of Appethyl® have been demonstrated in several clinical studies carried out at Lund University: Appethyl® was found to promote body weight reduction, reduce waist circumference and improve metabolic parameters such as cholesterol and glucose levels. Appethyl® works in a unique triple effect: lowering appetite, delaying absorption of fats, thereby triggering release of satiety hormones, and prolonging uptake of carbohydrates. The effects, use and production of thylakoids are protected via three pending patents, as well as one U.S. patent.

About Green PolkaDot Box

Green PolkaDot Box is America's premier online membership club for organic and non-GMO natural foods at wholesale pricing. The Company leverages proprietary technology and products with its dynamic, interactive website and member relationship management software to provide a unique shopping and membership experience. For more information on Green PolkaDot Box, please visit: www.greenpolkadotbox.com.

Safe Harbor Statement

This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as GPDB or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "Plans" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Investors Relations Contact
Rod Smith
CEO/Green PolkaDot Box Incorporated
(801) 787-8835